Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 072073
Company: IGI LABS INC
Company: IGI LABS INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | Discontinued | None | No | No |
| NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 200MG/10ML (20MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | Discontinued | None | No | No |